Note 3 - Acquisitions of Ownership Interests	6 Months Ended
Jun. 30, 2023
Notes to Financial Statements
Equity Method and Other Investments Disclosure [Text Block]	3. Acquisitions of Ownership Interests The following is a summary of additional deployments during the six month period ended June 30, 2023: The Company deployed $3.0 million to Prognos Health during the three months ended June 30, 2023. The Company had previously deployed an aggregate of $14.6 million. Prognos is a healthcare platform company transforming the ability to access, manage and analyze healthcare data in partnership with life sciences brands, payers, and clinical diagnostics organizations. The Company funded $0.3 million of convertible loans to Trice Medical during the three months ended March, 31 2023. The Company had previously deployed an aggregate of $12.0 million. Trice Medical is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.

Note 3 - Acquisitions of Ownership Interests

6 Months Ended

Jun. 30, 2023

Equity Method and Other Investments Disclosure [Text Block]

3. Acquisitions of Ownership Interests

The following is a summary of additional deployments during the six month period ended June 30, 2023:

The Company deployed $3.0 million to Prognos Health during the three months ended June 30, 2023. The Company had previously deployed an aggregate of $14.6 million. Prognos is a healthcare platform company transforming the ability to access, manage and analyze healthcare data in partnership with life sciences brands, payers, and clinical diagnostics organizations.

The Company funded $0.3 million of convertible loans to Trice Medical during the three months ended March, 31 2023. The Company had previously deployed an aggregate of $12.0 million. Trice Medical is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.